/DMTRF
DMTRF Stock - 3-D Matrix, Ltd.
Healthcare|Medical - DevicesOTC
$2.37+0.00%
+$0.00 (+0.00%) • Dec 19
80
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.61
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DMTRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.35 – $2.39
TARGET (TP)$2.73
STOP LOSS$2.18
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.18
52W High$2.37
52W Low$0.69
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.93B | $4.59B | $2.31B | $1.51B | $1.02B |
| Gross Profit | $4.42B | $3.09B | $1.29B | $661.01M | $304.91M |
| Gross Margin | 63.8% | 67.3% | 55.7% | 43.9% | 29.8% |
| Operating Income | $-1,156,167,000 | $-2,117,039,000 | $-3,158,344,000 | $-2,736,646,000 | $-2,648,637,000 |
| Net Income | $-2,501,245,000 | $-255,505,000 | $-2,445,978,000 | $-1,894,757,000 | $-2,012,615,000 |
| Net Margin | -36.1% | -5.6% | -105.7% | -125.8% | -196.5% |
| EPS | $-25.20 | $-3.49 | $-40.64 | $-37.20 | $-49.65 |
Company Overview
3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
DMTRFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.05
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 11, 2025 | — | $0.05 | — | — |
Q2 2025 | Jun 12, 2025 | — | $-0.07 | — | — |
Q1 2025 | Mar 13, 2025 | — | $-0.04 | — | — |
Q4 2024 | Dec 12, 2024 | — | $-0.00 | — | — |
Q3 2024 | Sep 12, 2024 | — | $-0.06 | — | — |
Q2 2024 | Jun 13, 2024 | — | $0.04 | — | — |
Q1 2024 | Mar 13, 2024 | — | $-0.05 | — | — |
Q4 2023 | Oct 31, 2023 | — | $-0.01 | — | — |
Q3 2023 | Jul 31, 2023 | — | $0.00 | — | — |
Q2 2023 | Apr 30, 2023 | — | $-0.04 | — | — |
Q1 2023 | Mar 17, 2023 | — | $-27.66 | — | — |
Q4 2022 | Dec 13, 2022 | — | $2.42 | — | — |
Q3 2022 | Sep 14, 2022 | — | $-9.24 | — | — |
Q2 2022 | Jun 14, 2022 | — | $3.21 | — | — |
Q1 2022 | Mar 15, 2022 | — | $-15.16 | — | — |
Q4 2021 | Dec 14, 2021 | — | $-9.09 | — | — |
Q3 2021 | Sep 14, 2021 | — | $-17.54 | — | — |
Q2 2021 | Jun 14, 2021 | — | $-10.33 | — | — |
Q1 2021 | Mar 16, 2021 | — | $-0.11 | — | — |
Q4 2020 | Dec 15, 2020 | — | $-16.67 | — | — |
Latest News
Loading news...
Frequently Asked Questions about DMTRF
What is DMTRF's current stock price?
3-D Matrix, Ltd. (DMTRF) is currently trading at $2.37 per share. The stock has moved +0.00% today.
What is the analyst price target for DMTRF?
No analyst price targets are currently available for this stock.
What sector is 3-D Matrix, Ltd. in?
3-D Matrix, Ltd. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is DMTRF's market cap?
3-D Matrix, Ltd. has a market capitalization of $0.28 billion, making it a small-cap company.
Does DMTRF pay dividends?
No, 3-D Matrix, Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABTI
Alterola Biotech, Inc.
$0.00
Mkt Cap: $0.0B
AONC
American Oncology Network, Inc.
$5.80
Mkt Cap: $0.2B
CMVLF
Cellectis S.A.
$4.50
Mkt Cap: $0.3B
EAPIF
Euroapi S.A.
$2.63
Mkt Cap: $0.3B
EDTXF
Spectral Medical Inc.
$0.90
Mkt Cap: $0.3B
HNSBF
Hansa Biopharma AB (publ)
$2.91
Mkt Cap: $0.2B
IDGXF
Integrated Diagnostics Holdings plc
$0.68
Mkt Cap: $0.4B
MAYNF
Mayne Pharma Group Limited
$2.36
Mkt Cap: $0.2B
ONVVF
Oneview Healthcare PLC
$0.16
Mkt Cap: $0.1B
TRGNF
Transgene S.A.
$1.00
Mkt Cap: $0.1B
Explore stocks similar to DMTRF for comparison